Global CMO and CDMO biotechnology Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 112

Published Date: 12 Jan 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global CMO and CDMO biotechnology market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global CMO and CDMO biotechnology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global CMO and CDMO biotechnology market size and forecasts, in consumption value ($ Million), 2018-2029
Global CMO and CDMO biotechnology market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global CMO and CDMO biotechnology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global CMO and CDMO biotechnology market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CMO and CDMO biotechnology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CMO and CDMO biotechnology market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Patheon, Catalent, Samsung Biologics, Lonza. and Boehringer Ingelheim, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
CMO and CDMO biotechnology market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Service
    Product
    Platform/ Expression System

Market segment by Application
    Large Enterprise
    SME

Market segment by players, this report covers
    Patheon
    Catalent
    Samsung Biologics
    Lonza.
    Boehringer Ingelheim
    Samsung BioLogics
    AGC Biologics
    WuXi Biologics
    AbbVie
    Avid Bioservices
    Fujifilm Diosynth Biotechnologies
    KBI Biopharma (JSR Corporation)
    Cytovance Biologics
    Xpress Biologic
    Rentschler Biopharma

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CMO and CDMO biotechnology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CMO and CDMO biotechnology, with revenue, gross margin and global market share of CMO and CDMO biotechnology from 2018 to 2023.
Chapter 3, the CMO and CDMO biotechnology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CMO and CDMO biotechnology market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of CMO and CDMO biotechnology.
Chapter 13, to describe CMO and CDMO biotechnology research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of CMO and CDMO biotechnology
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of CMO and CDMO biotechnology by Type
        1.3.1 Overview: Global CMO and CDMO biotechnology Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global CMO and CDMO biotechnology Consumption Value Market Share by Type in 2022
        1.3.3 Service
        1.3.4 Product
        1.3.5 Platform/ Expression System
    1.4 Global CMO and CDMO biotechnology Market by Application
        1.4.1 Overview: Global CMO and CDMO biotechnology Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Large Enterprise
        1.4.3 SME
    1.5 Global CMO and CDMO biotechnology Market Size & Forecast
    1.6 Global CMO and CDMO biotechnology Market Size and Forecast by Region
        1.6.1 Global CMO and CDMO biotechnology Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global CMO and CDMO biotechnology Market Size by Region, (2018-2029)
        1.6.3 North America CMO and CDMO biotechnology Market Size and Prospect (2018-2029)
        1.6.4 Europe CMO and CDMO biotechnology Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific CMO and CDMO biotechnology Market Size and Prospect (2018-2029)
        1.6.6 South America CMO and CDMO biotechnology Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa CMO and CDMO biotechnology Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Patheon
        2.1.1 Patheon Details
        2.1.2 Patheon Major Business
        2.1.3 Patheon CMO and CDMO biotechnology Product and Solutions
        2.1.4 Patheon CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Patheon Recent Developments and Future Plans
    2.2 Catalent
        2.2.1 Catalent Details
        2.2.2 Catalent Major Business
        2.2.3 Catalent CMO and CDMO biotechnology Product and Solutions
        2.2.4 Catalent CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Catalent Recent Developments and Future Plans
    2.3 Samsung Biologics
        2.3.1 Samsung Biologics Details
        2.3.2 Samsung Biologics Major Business
        2.3.3 Samsung Biologics CMO and CDMO biotechnology Product and Solutions
        2.3.4 Samsung Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Samsung Biologics Recent Developments and Future Plans
    2.4 Lonza.
        2.4.1 Lonza. Details
        2.4.2 Lonza. Major Business
        2.4.3 Lonza. CMO and CDMO biotechnology Product and Solutions
        2.4.4 Lonza. CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Lonza. Recent Developments and Future Plans
    2.5 Boehringer Ingelheim
        2.5.1 Boehringer Ingelheim Details
        2.5.2 Boehringer Ingelheim Major Business
        2.5.3 Boehringer Ingelheim CMO and CDMO biotechnology Product and Solutions
        2.5.4 Boehringer Ingelheim CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.6 Samsung BioLogics
        2.6.1 Samsung BioLogics Details
        2.6.2 Samsung BioLogics Major Business
        2.6.3 Samsung BioLogics CMO and CDMO biotechnology Product and Solutions
        2.6.4 Samsung BioLogics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Samsung BioLogics Recent Developments and Future Plans
    2.7 AGC Biologics
        2.7.1 AGC Biologics Details
        2.7.2 AGC Biologics Major Business
        2.7.3 AGC Biologics CMO and CDMO biotechnology Product and Solutions
        2.7.4 AGC Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 AGC Biologics Recent Developments and Future Plans
    2.8 WuXi Biologics
        2.8.1 WuXi Biologics Details
        2.8.2 WuXi Biologics Major Business
        2.8.3 WuXi Biologics CMO and CDMO biotechnology Product and Solutions
        2.8.4 WuXi Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 WuXi Biologics Recent Developments and Future Plans
    2.9 AbbVie
        2.9.1 AbbVie Details
        2.9.2 AbbVie Major Business
        2.9.3 AbbVie CMO and CDMO biotechnology Product and Solutions
        2.9.4 AbbVie CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 AbbVie Recent Developments and Future Plans
    2.10 Avid Bioservices
        2.10.1 Avid Bioservices Details
        2.10.2 Avid Bioservices Major Business
        2.10.3 Avid Bioservices CMO and CDMO biotechnology Product and Solutions
        2.10.4 Avid Bioservices CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Avid Bioservices Recent Developments and Future Plans
    2.11 Fujifilm Diosynth Biotechnologies
        2.11.1 Fujifilm Diosynth Biotechnologies Details
        2.11.2 Fujifilm Diosynth Biotechnologies Major Business
        2.11.3 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product and Solutions
        2.11.4 Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
    2.12 KBI Biopharma (JSR Corporation)
        2.12.1 KBI Biopharma (JSR Corporation) Details
        2.12.2 KBI Biopharma (JSR Corporation) Major Business
        2.12.3 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product and Solutions
        2.12.4 KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 KBI Biopharma (JSR Corporation) Recent Developments and Future Plans
    2.13 Cytovance Biologics
        2.13.1 Cytovance Biologics Details
        2.13.2 Cytovance Biologics Major Business
        2.13.3 Cytovance Biologics CMO and CDMO biotechnology Product and Solutions
        2.13.4 Cytovance Biologics CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Cytovance Biologics Recent Developments and Future Plans
    2.14 Xpress Biologic
        2.14.1 Xpress Biologic Details
        2.14.2 Xpress Biologic Major Business
        2.14.3 Xpress Biologic CMO and CDMO biotechnology Product and Solutions
        2.14.4 Xpress Biologic CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Xpress Biologic Recent Developments and Future Plans
    2.15 Rentschler Biopharma
        2.15.1 Rentschler Biopharma Details
        2.15.2 Rentschler Biopharma Major Business
        2.15.3 Rentschler Biopharma CMO and CDMO biotechnology Product and Solutions
        2.15.4 Rentschler Biopharma CMO and CDMO biotechnology Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Rentschler Biopharma Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global CMO and CDMO biotechnology Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of CMO and CDMO biotechnology by Company Revenue
        3.2.2 Top 3 CMO and CDMO biotechnology Players Market Share in 2022
        3.2.3 Top 6 CMO and CDMO biotechnology Players Market Share in 2022
    3.3 CMO and CDMO biotechnology Market: Overall Company Footprint Analysis
        3.3.1 CMO and CDMO biotechnology Market: Region Footprint
        3.3.2 CMO and CDMO biotechnology Market: Company Product Type Footprint
        3.3.3 CMO and CDMO biotechnology Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global CMO and CDMO biotechnology Consumption Value and Market Share by Type (2018-2023)
    4.2 Global CMO and CDMO biotechnology Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global CMO and CDMO biotechnology Consumption Value Market Share by Application (2018-2023)
    5.2 Global CMO and CDMO biotechnology Market Forecast by Application (2024-2029)

6 North America
    6.1 North America CMO and CDMO biotechnology Consumption Value by Type (2018-2029)
    6.2 North America CMO and CDMO biotechnology Consumption Value by Application (2018-2029)
    6.3 North America CMO and CDMO biotechnology Market Size by Country
        6.3.1 North America CMO and CDMO biotechnology Consumption Value by Country (2018-2029)
        6.3.2 United States CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        6.3.3 Canada CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        6.3.4 Mexico CMO and CDMO biotechnology Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe CMO and CDMO biotechnology Consumption Value by Type (2018-2029)
    7.2 Europe CMO and CDMO biotechnology Consumption Value by Application (2018-2029)
    7.3 Europe CMO and CDMO biotechnology Market Size by Country
        7.3.1 Europe CMO and CDMO biotechnology Consumption Value by Country (2018-2029)
        7.3.2 Germany CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        7.3.3 France CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        7.3.5 Russia CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        7.3.6 Italy CMO and CDMO biotechnology Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific CMO and CDMO biotechnology Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific CMO and CDMO biotechnology Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific CMO and CDMO biotechnology Market Size by Region
        8.3.1 Asia-Pacific CMO and CDMO biotechnology Consumption Value by Region (2018-2029)
        8.3.2 China CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        8.3.3 Japan CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        8.3.4 South Korea CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        8.3.5 India CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        8.3.7 Australia CMO and CDMO biotechnology Market Size and Forecast (2018-2029)

9 South America
    9.1 South America CMO and CDMO biotechnology Consumption Value by Type (2018-2029)
    9.2 South America CMO and CDMO biotechnology Consumption Value by Application (2018-2029)
    9.3 South America CMO and CDMO biotechnology Market Size by Country
        9.3.1 South America CMO and CDMO biotechnology Consumption Value by Country (2018-2029)
        9.3.2 Brazil CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        9.3.3 Argentina CMO and CDMO biotechnology Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa CMO and CDMO biotechnology Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa CMO and CDMO biotechnology Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa CMO and CDMO biotechnology Market Size by Country
        10.3.1 Middle East & Africa CMO and CDMO biotechnology Consumption Value by Country (2018-2029)
        10.3.2 Turkey CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia CMO and CDMO biotechnology Market Size and Forecast (2018-2029)
        10.3.4 UAE CMO and CDMO biotechnology Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 CMO and CDMO biotechnology Market Drivers
    11.2 CMO and CDMO biotechnology Market Restraints
    11.3 CMO and CDMO biotechnology Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 CMO and CDMO biotechnology Industry Chain
    12.2 CMO and CDMO biotechnology Upstream Analysis
    12.3 CMO and CDMO biotechnology Midstream Analysis
    12.4 CMO and CDMO biotechnology Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global CMO and CDMO biotechnology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global CMO and CDMO biotechnology Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global CMO and CDMO biotechnology Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global CMO and CDMO biotechnology Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Patheon Company Information, Head Office, and Major Competitors
    Table 6. Patheon Major Business
    Table 7. Patheon CMO and CDMO biotechnology Product and Solutions
    Table 8. Patheon CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Patheon Recent Developments and Future Plans
    Table 10. Catalent Company Information, Head Office, and Major Competitors
    Table 11. Catalent Major Business
    Table 12. Catalent CMO and CDMO biotechnology Product and Solutions
    Table 13. Catalent CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Catalent Recent Developments and Future Plans
    Table 15. Samsung Biologics Company Information, Head Office, and Major Competitors
    Table 16. Samsung Biologics Major Business
    Table 17. Samsung Biologics CMO and CDMO biotechnology Product and Solutions
    Table 18. Samsung Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Samsung Biologics Recent Developments and Future Plans
    Table 20. Lonza. Company Information, Head Office, and Major Competitors
    Table 21. Lonza. Major Business
    Table 22. Lonza. CMO and CDMO biotechnology Product and Solutions
    Table 23. Lonza. CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Lonza. Recent Developments and Future Plans
    Table 25. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
    Table 26. Boehringer Ingelheim Major Business
    Table 27. Boehringer Ingelheim CMO and CDMO biotechnology Product and Solutions
    Table 28. Boehringer Ingelheim CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Boehringer Ingelheim Recent Developments and Future Plans
    Table 30. Samsung BioLogics Company Information, Head Office, and Major Competitors
    Table 31. Samsung BioLogics Major Business
    Table 32. Samsung BioLogics CMO and CDMO biotechnology Product and Solutions
    Table 33. Samsung BioLogics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Samsung BioLogics Recent Developments and Future Plans
    Table 35. AGC Biologics Company Information, Head Office, and Major Competitors
    Table 36. AGC Biologics Major Business
    Table 37. AGC Biologics CMO and CDMO biotechnology Product and Solutions
    Table 38. AGC Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. AGC Biologics Recent Developments and Future Plans
    Table 40. WuXi Biologics Company Information, Head Office, and Major Competitors
    Table 41. WuXi Biologics Major Business
    Table 42. WuXi Biologics CMO and CDMO biotechnology Product and Solutions
    Table 43. WuXi Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. WuXi Biologics Recent Developments and Future Plans
    Table 45. AbbVie Company Information, Head Office, and Major Competitors
    Table 46. AbbVie Major Business
    Table 47. AbbVie CMO and CDMO biotechnology Product and Solutions
    Table 48. AbbVie CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. AbbVie Recent Developments and Future Plans
    Table 50. Avid Bioservices Company Information, Head Office, and Major Competitors
    Table 51. Avid Bioservices Major Business
    Table 52. Avid Bioservices CMO and CDMO biotechnology Product and Solutions
    Table 53. Avid Bioservices CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Avid Bioservices Recent Developments and Future Plans
    Table 55. Fujifilm Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
    Table 56. Fujifilm Diosynth Biotechnologies Major Business
    Table 57. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Product and Solutions
    Table 58. Fujifilm Diosynth Biotechnologies CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Fujifilm Diosynth Biotechnologies Recent Developments and Future Plans
    Table 60. KBI Biopharma (JSR Corporation) Company Information, Head Office, and Major Competitors
    Table 61. KBI Biopharma (JSR Corporation) Major Business
    Table 62. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Product and Solutions
    Table 63. KBI Biopharma (JSR Corporation) CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. KBI Biopharma (JSR Corporation) Recent Developments and Future Plans
    Table 65. Cytovance Biologics Company Information, Head Office, and Major Competitors
    Table 66. Cytovance Biologics Major Business
    Table 67. Cytovance Biologics CMO and CDMO biotechnology Product and Solutions
    Table 68. Cytovance Biologics CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Cytovance Biologics Recent Developments and Future Plans
    Table 70. Xpress Biologic Company Information, Head Office, and Major Competitors
    Table 71. Xpress Biologic Major Business
    Table 72. Xpress Biologic CMO and CDMO biotechnology Product and Solutions
    Table 73. Xpress Biologic CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Xpress Biologic Recent Developments and Future Plans
    Table 75. Rentschler Biopharma Company Information, Head Office, and Major Competitors
    Table 76. Rentschler Biopharma Major Business
    Table 77. Rentschler Biopharma CMO and CDMO biotechnology Product and Solutions
    Table 78. Rentschler Biopharma CMO and CDMO biotechnology Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. Rentschler Biopharma Recent Developments and Future Plans
    Table 80. Global CMO and CDMO biotechnology Revenue (USD Million) by Players (2018-2023)
    Table 81. Global CMO and CDMO biotechnology Revenue Share by Players (2018-2023)
    Table 82. Breakdown of CMO and CDMO biotechnology by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in CMO and CDMO biotechnology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 84. Head Office of Key CMO and CDMO biotechnology Players
    Table 85. CMO and CDMO biotechnology Market: Company Product Type Footprint
    Table 86. CMO and CDMO biotechnology Market: Company Product Application Footprint
    Table 87. CMO and CDMO biotechnology New Market Entrants and Barriers to Market Entry
    Table 88. CMO and CDMO biotechnology Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global CMO and CDMO biotechnology Consumption Value (USD Million) by Type (2018-2023)
    Table 90. Global CMO and CDMO biotechnology Consumption Value Share by Type (2018-2023)
    Table 91. Global CMO and CDMO biotechnology Consumption Value Forecast by Type (2024-2029)
    Table 92. Global CMO and CDMO biotechnology Consumption Value by Application (2018-2023)
    Table 93. Global CMO and CDMO biotechnology Consumption Value Forecast by Application (2024-2029)
    Table 94. North America CMO and CDMO biotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 95. North America CMO and CDMO biotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 96. North America CMO and CDMO biotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. North America CMO and CDMO biotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. North America CMO and CDMO biotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 99. North America CMO and CDMO biotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 100. Europe CMO and CDMO biotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Europe CMO and CDMO biotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Europe CMO and CDMO biotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 103. Europe CMO and CDMO biotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 104. Europe CMO and CDMO biotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe CMO and CDMO biotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific CMO and CDMO biotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 107. Asia-Pacific CMO and CDMO biotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 108. Asia-Pacific CMO and CDMO biotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 109. Asia-Pacific CMO and CDMO biotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 110. Asia-Pacific CMO and CDMO biotechnology Consumption Value by Region (2018-2023) & (USD Million)
    Table 111. Asia-Pacific CMO and CDMO biotechnology Consumption Value by Region (2024-2029) & (USD Million)
    Table 112. South America CMO and CDMO biotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 113. South America CMO and CDMO biotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 114. South America CMO and CDMO biotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 115. South America CMO and CDMO biotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 116. South America CMO and CDMO biotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. South America CMO and CDMO biotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Middle East & Africa CMO and CDMO biotechnology Consumption Value by Type (2018-2023) & (USD Million)
    Table 119. Middle East & Africa CMO and CDMO biotechnology Consumption Value by Type (2024-2029) & (USD Million)
    Table 120. Middle East & Africa CMO and CDMO biotechnology Consumption Value by Application (2018-2023) & (USD Million)
    Table 121. Middle East & Africa CMO and CDMO biotechnology Consumption Value by Application (2024-2029) & (USD Million)
    Table 122. Middle East & Africa CMO and CDMO biotechnology Consumption Value by Country (2018-2023) & (USD Million)
    Table 123. Middle East & Africa CMO and CDMO biotechnology Consumption Value by Country (2024-2029) & (USD Million)
    Table 124. CMO and CDMO biotechnology Raw Material
    Table 125. Key Suppliers of CMO and CDMO biotechnology Raw Materials
List of Figures
    Figure 1. CMO and CDMO biotechnology Picture
    Figure 2. Global CMO and CDMO biotechnology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global CMO and CDMO biotechnology Consumption Value Market Share by Type in 2022
    Figure 4. Service
    Figure 5. Product
    Figure 6. Platform/ Expression System
    Figure 7. Global CMO and CDMO biotechnology Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. CMO and CDMO biotechnology Consumption Value Market Share by Application in 2022
    Figure 9. Large Enterprise Picture
    Figure 10. SME Picture
    Figure 11. Global CMO and CDMO biotechnology Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global CMO and CDMO biotechnology Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market CMO and CDMO biotechnology Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global CMO and CDMO biotechnology Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global CMO and CDMO biotechnology Consumption Value Market Share by Region in 2022
    Figure 16. North America CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global CMO and CDMO biotechnology Revenue Share by Players in 2022
    Figure 22. CMO and CDMO biotechnology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players CMO and CDMO biotechnology Market Share in 2022
    Figure 24. Global Top 6 Players CMO and CDMO biotechnology Market Share in 2022
    Figure 25. Global CMO and CDMO biotechnology Consumption Value Share by Type (2018-2023)
    Figure 26. Global CMO and CDMO biotechnology Market Share Forecast by Type (2024-2029)
    Figure 27. Global CMO and CDMO biotechnology Consumption Value Share by Application (2018-2023)
    Figure 28. Global CMO and CDMO biotechnology Market Share Forecast by Application (2024-2029)
    Figure 29. North America CMO and CDMO biotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America CMO and CDMO biotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America CMO and CDMO biotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe CMO and CDMO biotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe CMO and CDMO biotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe CMO and CDMO biotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 39. France CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific CMO and CDMO biotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific CMO and CDMO biotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific CMO and CDMO biotechnology Consumption Value Market Share by Region (2018-2029)
    Figure 46. China CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 49. India CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America CMO and CDMO biotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America CMO and CDMO biotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America CMO and CDMO biotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa CMO and CDMO biotechnology Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa CMO and CDMO biotechnology Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa CMO and CDMO biotechnology Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE CMO and CDMO biotechnology Consumption Value (2018-2029) & (USD Million)
    Figure 63. CMO and CDMO biotechnology Market Drivers
    Figure 64. CMO and CDMO biotechnology Market Restraints
    Figure 65. CMO and CDMO biotechnology Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of CMO and CDMO biotechnology in 2022
    Figure 68. Manufacturing Process Analysis of CMO and CDMO biotechnology
    Figure 69. CMO and CDMO biotechnology Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Patheon
Catalent
Samsung Biologics
Lonza.
Boehringer Ingelheim
Samsung BioLogics
AGC Biologics
WuXi Biologics
AbbVie
Avid Bioservices
Fujifilm Diosynth Biotechnologies
KBI Biopharma (JSR Corporation)
Cytovance Biologics
Xpress Biologic
Rentschler Biopharma

Related Reports

Global CMO and CDMO biotechnology Supply, Demand and Key Producers, 2023-2029

Global CMO and CDMO biotechnology Supply, Demand and Key Producers, 2023-2029

date 08 Feb 2023

date Service & Software

The global CMO and CDMO biotechnology market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global CMO and CDMO biotechnology Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CMO and CDMO biotechnology Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 03 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global CMO and CDMO biotechnology market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global CMO and CDMO biotechnology Supply, Demand and Key Producers, 2024-2030

Global CMO and CDMO biotechnology Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Service & Software

The global CMO and CDMO biotechnology market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

CMO and CDMO biotechnology

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>